This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-141-3p | ACADSB | -0.35 | 0.257 | -2.11 | 0 | MirTarget | -0.11 | 0.00127 | NA | |
2 | hsa-miR-141-3p | ACO1 | -0.35 | 0.257 | -0.9 | 0 | MirTarget; TargetScan | -0.12 | 0 | NA | |
3 | hsa-miR-141-3p | ADRB1 | -0.35 | 0.257 | -2.23 | 0 | TargetScan | -0.15 | 0.0028 | NA | |
4 | hsa-miR-141-3p | APOH | -0.35 | 0.257 | -1.63 | 0 | TargetScan | -0.21 | 6.0E-5 | NA | |
5 | hsa-miR-141-3p | APOLD1 | -0.35 | 0.257 | 0.45 | 0.00929 | TargetScan | -0.14 | 0 | NA | |
6 | hsa-miR-141-3p | AR | -0.35 | 0.257 | -2.66 | 0 | mirMAP | -0.41 | 0 | 26062412; 22314666 | miR 141 3p regulates the expression of androgen receptor by targeting its 3'UTR in prostate cancer LNCaP cells; After prostate cancer cell line LNCaP was transfected with miR-141-3p mimics expression levels of AR mRNA and protein in the LNCaP cells were detected by reverse transcription PCR and Western blotting respectively; The 3'untranslated regions 3'UTR of AR mRNA containing the binding site of miR-141-3p was amplified by PCR and inserted into pmiR-report vector a 3'downstream luciferase reporter gene; Transfection of miR-141-3p mimics decreased both mRNA and protein expression levels of AR in LNCaP cells; AR is a direct target gene of miR-141-3p;miR 141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein; Here we investigated the correlation of Shp expression with the cellular level of miR-141 and its effects on AR transcriptional activity in non-malignant and malignant human prostate epithelial cell lines; Phenethyl isothiocyanate a natural constituent of many edible cruciferous vegetables increased Shp expression downregulated miR-141 and inhibited AR transcriptional activity in LNCaP cells; Shp is a target for miR-141 and it is downregulated in cultured human PCa cells with the involvement of upregulation of miR-141 which promotes AR transcriptional activity |
7 | hsa-miR-141-3p | ATXN7L1 | -0.35 | 0.257 | -0.24 | 0.06065 | TargetScan; miRNATAP | -0.11 | 0 | NA | |
8 | hsa-miR-141-3p | C1orf21 | -0.35 | 0.257 | -0.75 | 0.00045 | TargetScan; miRNATAP | -0.14 | 3.0E-5 | NA | |
9 | hsa-miR-141-3p | CADM1 | -0.35 | 0.257 | -0.03 | 0.88629 | MirTarget; TargetScan | -0.18 | 0 | NA | |
10 | hsa-miR-141-3p | CDC14B | -0.35 | 0.257 | -1.19 | 0 | mirMAP | -0.2 | 0 | NA | |
11 | hsa-miR-141-3p | CDK6 | -0.35 | 0.257 | -0.31 | 0.22057 | TargetScan; miRNATAP | -0.14 | 0.00031 | NA | |
12 | hsa-miR-141-3p | CELF6 | -0.35 | 0.257 | 1.59 | 0 | TargetScan | -0.14 | 0.00018 | NA | |
13 | hsa-miR-141-3p | CFL2 | -0.35 | 0.257 | -1.18 | 0 | TargetScan | -0.15 | 0 | NA | |
14 | hsa-miR-141-3p | CLYBL | -0.35 | 0.257 | -1.25 | 0 | mirMAP | -0.17 | 0 | NA | |
15 | hsa-miR-141-3p | CPEB3 | -0.35 | 0.257 | -2.74 | 0 | MirTarget | -0.13 | 0.00026 | NA | |
16 | hsa-miR-141-3p | CPLX2 | -0.35 | 0.257 | 5.16 | 0 | mirMAP | -0.47 | 8.0E-5 | NA | |
17 | hsa-miR-141-3p | DDI2 | -0.35 | 0.257 | -1.53 | 0 | mirMAP | -0.13 | 0.0105 | NA | |
18 | hsa-miR-141-3p | DYNC1I1 | -0.35 | 0.257 | 1.67 | 1.0E-5 | MirTarget | -0.18 | 0.00244 | NA | |
19 | hsa-miR-141-3p | ELL2 | -0.35 | 0.257 | -0.77 | 0 | TargetScan | -0.13 | 0 | NA | |
20 | hsa-miR-141-3p | FAM169A | -0.35 | 0.257 | 0.37 | 0.13291 | mirMAP | -0.12 | 0.00113 | NA | |
21 | hsa-miR-141-3p | FKBP5 | -0.35 | 0.257 | -0.23 | 0.1942 | TargetScan | -0.12 | 2.0E-5 | NA | |
22 | hsa-miR-141-3p | GFRA1 | -0.35 | 0.257 | -2.55 | 0 | mirMAP | -0.26 | 0.00043 | NA | |
23 | hsa-miR-141-3p | GFRA2 | -0.35 | 0.257 | -1.04 | 0 | mirMAP | -0.17 | 0 | NA | |
24 | hsa-miR-141-3p | GLRX | -0.35 | 0.257 | -0.98 | 0 | MirTarget; TargetScan; miRNATAP | -0.11 | 3.0E-5 | NA | |
25 | hsa-miR-141-3p | GNE | -0.35 | 0.257 | -1.82 | 0 | MirTarget | -0.16 | 0 | NA | |
26 | hsa-miR-141-3p | GNG7 | -0.35 | 0.257 | -0.34 | 0.08092 | MirTarget; TargetScan; miRNATAP | -0.14 | 0 | NA | |
27 | hsa-miR-141-3p | GNPTG | -0.35 | 0.257 | 0.04 | 0.71843 | TargetScan | -0.11 | 0 | NA | |
28 | hsa-miR-141-3p | GPAM | -0.35 | 0.257 | -0.47 | 0.0638 | MirTarget | -0.1 | 0.00991 | NA | |
29 | hsa-miR-141-3p | GPD1 | -0.35 | 0.257 | -2.61 | 0 | TargetScan | -0.17 | 0.00103 | NA | |
30 | hsa-miR-141-3p | GPHN | -0.35 | 0.257 | -1.46 | 0 | TargetScan; miRNATAP | -0.16 | 0 | NA | |
31 | hsa-miR-141-3p | HLF | -0.35 | 0.257 | -1.56 | 0 | TargetScan | -0.31 | 0 | NA | |
32 | hsa-miR-141-3p | HNMT | -0.35 | 0.257 | -0.67 | 0 | TargetScan | -0.11 | 0 | NA | |
33 | hsa-miR-141-3p | HOMER2 | -0.35 | 0.257 | -1.01 | 6.0E-5 | mirMAP | -0.12 | 0.00188 | NA | |
34 | hsa-miR-141-3p | HS3ST3B1 | -0.35 | 0.257 | -2.61 | 0 | mirMAP | -0.16 | 0.00159 | NA | |
35 | hsa-miR-141-3p | IL6R | -0.35 | 0.257 | -0.2 | 0.38255 | MirTarget | -0.14 | 5.0E-5 | NA | |
36 | hsa-miR-141-3p | IRS2 | -0.35 | 0.257 | -0.81 | 1.0E-5 | MirTarget; TargetScan; miRNATAP | -0.16 | 0 | 27186273 | Forced expression of IRS2 reversed the inhibition effect induced by miR-141 overexpression in thyroid cancer cells; Taken together our study provides the first evidence that miR-141 suppressed thyroid cancer cell growth and metastasis through inhibition of IRS2 |
37 | hsa-miR-141-3p | IYD | -0.35 | 0.257 | -2.66 | 0 | mirMAP | -0.16 | 0.00599 | NA | |
38 | hsa-miR-141-3p | KLF12 | -0.35 | 0.257 | -0.86 | 0 | MirTarget; TargetScan | -0.13 | 0 | NA | |
39 | hsa-miR-141-3p | KLHDC10 | -0.35 | 0.257 | -0.3 | 0.0707 | TargetScan | -0.14 | 0 | NA | |
40 | hsa-miR-141-3p | MFAP3L | -0.35 | 0.257 | -3 | 0 | MirTarget | -0.17 | 0.00223 | NA | |
41 | hsa-miR-141-3p | MOCS2 | -0.35 | 0.257 | -0.17 | 0.11041 | TargetScan | -0.13 | 0 | NA | |
42 | hsa-miR-141-3p | MTSS1 | -0.35 | 0.257 | -0.16 | 0.21015 | TargetScan; miRNATAP | -0.11 | 0 | NA | |
43 | hsa-miR-141-3p | MYRIP | -0.35 | 0.257 | -1.63 | 2.0E-5 | MirTarget; TargetScan | -0.49 | 0 | NA | |
44 | hsa-miR-141-3p | NFIA | -0.35 | 0.257 | -0.92 | 0 | TargetScan; miRNATAP | -0.13 | 0 | NA | |
45 | hsa-miR-141-3p | NUDT12 | -0.35 | 0.257 | -0.91 | 2.0E-5 | MirTarget | -0.19 | 0 | NA | |
46 | hsa-miR-141-3p | NUDT16 | -0.35 | 0.257 | -0.31 | 0.00173 | mirMAP | -0.12 | 0 | NA | |
47 | hsa-miR-141-3p | PDXP | -0.35 | 0.257 | -0.39 | 0.00374 | TargetScan | -0.12 | 0 | NA | |
48 | hsa-miR-141-3p | PGRMC1 | -0.35 | 0.257 | -0.9 | 0 | TargetScan | -0.16 | 0 | NA | |
49 | hsa-miR-141-3p | PHLPP1 | -0.35 | 0.257 | -0.74 | 0 | MirTarget; TargetScan; miRNATAP | -0.12 | 0 | 24945731 | MicroRNA 141 promotes the proliferation of non small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2; Together the results of this study suggest that miR-141 and its targets PHLPP1 and PHLPP2 play critical roles in NSCLC tumorigenesis and provide potential therapeutic targets for NSCLC treatment |
50 | hsa-miR-141-3p | PHYHIPL | -0.35 | 0.257 | 0.88 | 0.00299 | MirTarget; TargetScan; miRNATAP | -0.11 | 0.01435 | NA | |
51 | hsa-miR-141-3p | PPARA | -0.35 | 0.257 | -0.61 | 3.0E-5 | miRNAWalker2 validate; miRTarBase | -0.12 | 0 | NA | |
52 | hsa-miR-141-3p | PPP1R3G | -0.35 | 0.257 | -0.77 | 0.03361 | TargetScan | -0.2 | 0.00048 | NA | |
53 | hsa-miR-141-3p | RAD54L2 | -0.35 | 0.257 | -0.97 | 1.0E-5 | TargetScan | -0.1 | 0.00219 | NA | |
54 | hsa-miR-141-3p | RBM24 | -0.35 | 0.257 | 1.89 | 0 | TargetScan | -0.23 | 0 | NA | |
55 | hsa-miR-141-3p | RNF217 | -0.35 | 0.257 | -0.87 | 3.0E-5 | mirMAP | -0.11 | 0.00076 | NA | |
56 | hsa-miR-141-3p | RORA | -0.35 | 0.257 | -1.19 | 0 | MirTarget; TargetScan; miRNATAP | -0.12 | 3.0E-5 | NA | |
57 | hsa-miR-141-3p | RSPO2 | -0.35 | 0.257 | -1.48 | 0.00047 | MirTarget | -0.27 | 4.0E-5 | NA | |
58 | hsa-miR-141-3p | SCP2 | -0.35 | 0.257 | -1.7 | 0 | miRNATAP | -0.15 | 0 | NA | |
59 | hsa-miR-141-3p | SDC2 | -0.35 | 0.257 | -0.03 | 0.81477 | MirTarget; TargetScan | -0.11 | 0 | NA | |
60 | hsa-miR-141-3p | SERPINC1 | -0.35 | 0.257 | -1.64 | 4.0E-5 | TargetScan | -0.34 | 0 | NA | |
61 | hsa-miR-141-3p | SFXN1 | -0.35 | 0.257 | -0.99 | 0 | TargetScan | -0.12 | 0 | NA | |
62 | hsa-miR-141-3p | SLC16A7 | -0.35 | 0.257 | -1.26 | 2.0E-5 | MirTarget; TargetScan; miRNATAP | -0.1 | 0.0259 | NA | |
63 | hsa-miR-141-3p | SLC1A1 | -0.35 | 0.257 | -2.49 | 0 | TargetScan; miRNATAP | -0.12 | 0.03924 | NA | |
64 | hsa-miR-141-3p | SLC23A2 | -0.35 | 0.257 | -0.58 | 0.00102 | TargetScan; miRNATAP | -0.14 | 0 | NA | |
65 | hsa-miR-141-3p | SLC25A42 | -0.35 | 0.257 | -0.84 | 0 | mirMAP | -0.13 | 0 | NA | |
66 | hsa-miR-141-3p | SLC30A1 | -0.35 | 0.257 | -1.21 | 0 | TargetScan | -0.11 | 6.0E-5 | NA | |
67 | hsa-miR-141-3p | SORBS2 | -0.35 | 0.257 | -1.05 | 0 | MirTarget; TargetScan | -0.13 | 1.0E-5 | NA | |
68 | hsa-miR-141-3p | SPPL2A | -0.35 | 0.257 | -0.16 | 0.10882 | TargetScan | -0.1 | 0 | NA | |
69 | hsa-miR-141-3p | SSTR1 | -0.35 | 0.257 | -1.62 | 1.0E-5 | mirMAP | -0.27 | 0 | NA | |
70 | hsa-miR-141-3p | ST3GAL3 | -0.35 | 0.257 | 0.05 | 0.68974 | MirTarget; TargetScan; miRNATAP | -0.14 | 0 | NA | |
71 | hsa-miR-141-3p | TAPT1 | -0.35 | 0.257 | -1.13 | 0 | TargetScan | -0.11 | 0 | NA | |
72 | hsa-miR-141-3p | THRB | -0.35 | 0.257 | -0.63 | 0 | MirTarget; TargetScan; miRNATAP | -0.1 | 0 | NA | |
73 | hsa-miR-141-3p | TMEM192 | -0.35 | 0.257 | -1.03 | 0 | TargetScan | -0.12 | 0 | NA | |
74 | hsa-miR-141-3p | TMEM56 | -0.35 | 0.257 | -1.76 | 0 | MirTarget; TargetScan; miRNATAP | -0.15 | 0 | NA | |
75 | hsa-miR-141-3p | TTR | -0.35 | 0.257 | -2.49 | 0 | MirTarget; TargetScan; miRNATAP | -0.2 | 0.00066 | NA | |
76 | hsa-miR-141-3p | UGT1A1 | -0.35 | 0.257 | -2.58 | 0 | TargetScan | -0.31 | 0 | NA | |
77 | hsa-miR-141-3p | UGT1A3 | -0.35 | 0.257 | -2.58 | 0 | MirTarget; TargetScan | -0.46 | 0 | NA | |
78 | hsa-miR-141-3p | UGT1A4 | -0.35 | 0.257 | -3.36 | 0 | MirTarget; TargetScan | -0.56 | 0 | NA | |
79 | hsa-miR-141-3p | UGT1A5 | -0.35 | 0.257 | -2.24 | 0 | MirTarget; TargetScan | -0.4 | 0 | NA | |
80 | hsa-miR-141-3p | UGT1A6 | -0.35 | 0.257 | -1.16 | 0.00102 | MirTarget; TargetScan | -0.17 | 0.0025 | NA | |
81 | hsa-miR-141-3p | UGT1A9 | -0.35 | 0.257 | -1.35 | 0.00014 | MirTarget; TargetScan | -0.28 | 0 | NA | |
82 | hsa-miR-141-3p | USH2A | -0.35 | 0.257 | -2.27 | 0 | MirTarget | -0.15 | 0.00466 | NA | |
83 | hsa-miR-141-3p | WNK3 | -0.35 | 0.257 | -0.84 | 0.00786 | mirMAP | -0.18 | 0.00024 | NA | |
84 | hsa-miR-141-3p | ZBTB16 | -0.35 | 0.257 | -1.17 | 0.0001 | TargetScan | -0.28 | 0 | NA | |
85 | hsa-miR-141-3p | ZCCHC24 | -0.35 | 0.257 | -1.09 | 0 | MirTarget; TargetScan; miRNATAP | -0.12 | 0 | NA | |
86 | hsa-miR-141-3p | ZFAND5 | -0.35 | 0.257 | -0.9 | 0 | TargetScan | -0.11 | 3.0E-5 | NA | |
87 | hsa-miR-141-3p | ZNF385D | -0.35 | 0.257 | 1.93 | 1.0E-5 | MirTarget; TargetScan | -0.28 | 3.0E-5 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELLULAR GLUCURONIDATION | 6 | 22 | 4.012e-10 | 1.867e-06 |
2 | GLUCURONATE METABOLIC PROCESS | 6 | 27 | 1.564e-09 | 2.308e-06 |
3 | URONIC ACID METABOLIC PROCESS | 6 | 27 | 1.564e-09 | 2.308e-06 |
4 | FLAVONOID METABOLIC PROCESS | 6 | 28 | 1.984e-09 | 2.308e-06 |
5 | REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 10 | 172 | 3.848e-09 | 3.581e-06 |
6 | REGULATION OF LIPID METABOLIC PROCESS | 11 | 282 | 3.909e-08 | 3.031e-05 |
7 | SMALL MOLECULE METABOLIC PROCESS | 25 | 1767 | 7.461e-08 | 4.959e-05 |
8 | REGULATION OF FATTY ACID METABOLIC PROCESS | 7 | 87 | 1.017e-07 | 5.731e-05 |
9 | NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 6 | 53 | 1.108e-07 | 5.731e-05 |
10 | NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 5 | 29 | 1.517e-07 | 7.056e-05 |
11 | MONOSACCHARIDE METABOLIC PROCESS | 9 | 202 | 2.378e-07 | 0.0001006 |
12 | RESPONSE TO XENOBIOTIC STIMULUS | 7 | 105 | 3.718e-07 | 0.0001442 |
13 | DRUG METABOLIC PROCESS | 5 | 39 | 7.106e-07 | 0.0002543 |
14 | COFACTOR CATABOLIC PROCESS | 4 | 20 | 1.534e-06 | 0.00051 |
15 | ORGANIC ACID METABOLIC PROCESS | 16 | 953 | 3.056e-06 | 0.0009479 |
16 | REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 7 | 173 | 1.048e-05 | 0.003047 |
17 | NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 5 | 80 | 2.579e-05 | 0.00706 |
18 | CARBOHYDRATE METABOLIC PROCESS | 12 | 662 | 2.87e-05 | 0.007418 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | GLUCURONOSYLTRANSFERASE ACTIVITY | 6 | 34 | 6.937e-09 | 6.444e-06 |
2 | RETINOIC ACID BINDING | 5 | 23 | 4.386e-08 | 2.037e-05 |
3 | PROTEIN HOMODIMERIZATION ACTIVITY | 15 | 722 | 4.686e-07 | 0.0001088 |
4 | MONOCARBOXYLIC ACID BINDING | 6 | 65 | 3.825e-07 | 0.0001088 |
5 | ISOPRENOID BINDING | 5 | 40 | 8.093e-07 | 0.0001504 |
6 | PROTEIN DIMERIZATION ACTIVITY | 18 | 1149 | 1.789e-06 | 0.000277 |
7 | IDENTICAL PROTEIN BINDING | 18 | 1209 | 3.667e-06 | 0.0004867 |
8 | LIPID BINDING | 12 | 657 | 2.665e-05 | 0.003094 |
9 | ORGANIC ACID BINDING | 7 | 209 | 3.545e-05 | 0.003293 |
10 | UDP GLYCOSYLTRANSFERASE ACTIVITY | 6 | 139 | 3.217e-05 | 0.003293 |
11 | STEROID BINDING | 5 | 91 | 4.806e-05 | 0.004059 |
12 | TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING | 4 | 48 | 5.616e-05 | 0.004347 |
13 | STEROID HORMONE RECEPTOR ACTIVITY | 4 | 59 | 0.0001267 | 0.009051 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Peroxisome_hsa04146 | 2 | 83 | 0.05074 | 0.8541 | |
2 | cAMP_signaling_pathway_hsa04024 | 3 | 198 | 0.05536 | 0.8541 | |
3 | PI3K_Akt_signaling_pathway_hsa04151 | 4 | 352 | 0.06751 | 0.8541 | |
4 | Cell_cycle_hsa04110 | 2 | 124 | 0.1016 | 0.8541 | |
5 | Oocyte_meiosis_hsa04114 | 2 | 124 | 0.1016 | 0.8541 | |
6 | FoxO_signaling_pathway_hsa04068 | 2 | 132 | 0.1127 | 0.8541 | |
7 | Neuroactive_ligand_receptor_interaction_hsa04080 | 3 | 278 | 0.1209 | 0.8541 | |
8 | Cell_adhesion_molecules_.CAMs._hsa04514 | 2 | 145 | 0.1314 | 0.8541 | |
9 | cGMP_PKG_signaling_pathway_hsa04022 | 2 | 163 | 0.1583 | 0.9147 |